Skip to main content

Peer Review reports

From: Efficacy and safety of secukinumab in patients with giant cell arteritis: study protocol for a randomized, parallel group, double-blind, placebo-controlled phase II trial

Original Submission
23 Jun 2020 Submitted Original manuscript
8 Dec 2020 Reviewed Reviewer Report - Ines Rombach
25 Jan 2021 Reviewed Reviewer Report - Kirsty Loudon
4 Apr 2021 Reviewed Reviewer Report - Kenneth Warrington
15 May 2021 Author responded Author comments - Nils Venhoff
Resubmission - Version 2
15 May 2021 Submitted Manuscript version 2
7 Jun 2021 Reviewed Reviewer Report - Kenneth Warrington
18 Jun 2021 Reviewed Reviewer Report - Kirsty Loudon
20 Jun 2021 Reviewed Reviewer Report - Ines Rombach
23 Jul 2021 Author responded Author comments - Nils Venhoff
Resubmission - Version 3
23 Jul 2021 Submitted Manuscript version 3
28 Jul 2021 Reviewed Reviewer Report - Kirsty Loudon
1 Aug 2021 Reviewed Reviewer Report - Ines Rombach
Resubmission - Version 4
Submitted Manuscript version 4
Publishing
6 Aug 2021 Editorially accepted
17 Aug 2021 Article published 10.1186/s13063-021-05520-1

You can find further information about peer review here.

Back to article page